miRNAs have been reported to alter the expression of molecules, e.g., PD-L1 [71], which, like CD200:CD200R, are known members of the checkpoint inhibitor family, which can also modulate host anti-tumor responses [12]. The gene discussed is CD200R1; the disease is neoplasm.